Home > Collaborations > Companion Diagnostics
Companion Diagnostics

Companion Diagnostics, a new diagnostic section for detecting biomarker(s) used in a specific context that provides biological or clinical information that enables better decision-making about the development and use of a potential drug therapy, is drawing wide attention from pharmaceutical companies, reimbursement providers and regulatory bodies. It is getting applicable in wider spectrum in a new era of personalized medicine.

Ustar Biotechnologies possesses a unique SNP/Mutation detection platform based on Allele Specific Polymerase Chain Reaction (AS-PCR) technology and the disposable contamination-proof DNA amplicon detection device. The platform-based Ustar diagnostic kit is potentially useful as a quick, easy-to-use and low-cost tool for SNP or mutation detection during research and clinical trial stages as well as companion diagnostic tests related to particular therapies.

The Platform Technologies include:
 Allele Specific Polymerase Chain Reaction, AS-PCR
 Disposable and contamination-proof DNA amplicon detection device.
Ustar Biotechnologies sincerely invites collaborations in following areas:
 Co-development of rapid and easy-to-use SNP/Mutation detection tools intended for use in pharmaceutical research, development and clinical trials;
      Collaboration projects with pharmaceutical and companion diagnostics companies on biomarkers screening tools development;
 Co-development of bio-markers detection kits tailored to specific clinically intended uses


Contact Us :